Ridgetech, Inc. Ordinary Shares (RDGT) — Analysis Summary
Ridgetech, Inc. Ordinary Shares (RDGT) has a market cap of $3.27M with year-over-year revenue growth of +10.2%. Net margin stands at -0.9%. The stock trades at a P/E ratio of -2.6.
Key Takeaways
- Revenue changed +10.2% year-over-year
- Net margin of -0.9%
- P/E ratio of -2.6
Compared with its sector, RDGT posted revenue growth of +10.2% and trades at a P/E of -2.6.
Ridgetech, Inc. Ordinary Shares (RDGT)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -27.8x — earnings do not cover interest payments
The latest filing shows negative free cash flow.
Ridgetech Inc is a wholesale distributor of pharmaceutical and other healthcare products. Currently operate in the offline wholesale distribution of pharmaceutical products mainly to local buyers, while also engaging in online sales through both self-operated and third-party platforms to customers nationwide. The company wholesale business through Jiuxin Medicine, distributing third-party pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine (TCM), personal and family care products, and medical devices, as well as convenience products, including consumable, seasonal, and promotional items. It has two segments offline wholesale and online platform. The majority revenue generated from offline wholesale.
Employees
64
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.